Rachael D. Migler

Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors

Krista Y. Chen, Aleksandra Popović, David Hsiehchen et al. · Cancers · 2022 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma

Bassem Shebl, Denise Ng, Gadi Lalazar et al. · JCI Insight · 2022 · 27 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical and demographic predictors of survival for fibrolamellar carcinoma patients—A patient community, registry‐based study

Amichai Berkovitz, Rachael D. Migler, Adam Qureshi et al. · Hepatology Communications · 2022 · 13 citations · Full text

Medicine, Biostatistics, Oncology +17

Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma

Solomon Levin, Michael D. Tomasini, James Knox et al. · Science Advances · 2023 · 11 citations · Full text

Medicine, Cell Biology, Oncology +17